Request Demo
Last update 14 Oct 2025
KH-607
Last update 14 Oct 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms KH 607, KH-607, KH607 |
Target |
Action positive allosteric modulator |
Mechanism GABAA receptor positive allosteric modulator(Gamma-aminobutyric acid A receptor positive allosteric modulator) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with KH-607NCT07101120
A Phase 2, Two-Part (Open-Label Followed by Double-Blind) Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of KH607 in the Treatment of Adult Participants With Moderate or Severe Major Depressive Disorder
NCT07096791
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of KH607 in the Treatment of Adult Female Participants With Postpartum Depressive Disorder
NCT06393803
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of Single and Multiple Doses of KH607 Tablets in Chinese Healthy Volunteers
100 Clinical Results associated with KH-607
Login to view more data
100 Translational Medicine associated with KH-607
Login to view more data
100 Patents (Medical) associated with KH-607
Login to view more data
100 Deals associated with KH-607
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Depression, Postpartum | Phase 2 | - | 01 Jul 2025 | |
| Depressive Disorder, Major | Phase 2 | China | 19 Mar 2025 | |
| Major depressive disorder, moderate (MDD) | Phase 2 | China | 19 Mar 2025 | |
| Depressive Disorder | IND Approval | United States | 24 Oct 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free